Pooja Gupta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Pooja Gupta has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Desiree Therese Blossom D'Souza
The Foundation for Medical Research, 84-A, R.G. Thadani Marg, Worli, Mumbai 400018, Maharashtra, India
1 shared publication - Monica Prem Tolani
The Foundation for Medical Research, 84-A, R.G. Thadani Marg, Worli, Mumbai 400018, Maharashtra, India
1 shared publication - Nerges Mistry
The Foundation for Medical Research (FMR), Mumbai, India
1 shared publication - Poonam Daswani
The Foundation for Medical Research, 84-A, R.G. Thadani Marg, Worli, Mumbai 400018, Maharashtra, India
1 shared publication - Pundarikakshudu Tetali
Temple Rose Livestock Farming Pvt. Ltd
1 shared publication - Purva Bhatter
Post Doc in Tuberculosis Immunology from Indian Institute of Technology, Madras, Chennai, India
1 shared publication
Latest Publications
- Open Access
- 4 March 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 84
Evaluating the anti Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays
In tuberculosis (TB), the steadily increasing bacterial resistance to existing drugs and latent TB continue to be major concerns. A combination of conventional drugs and plant derived therapeutics can serve to expand the antimicrobial spectrum, prevent the emergence of drug resistant mutants and minimize toxicity. Alpinia galanga, used in various traditional medicines, possesses broad spectrum antibacterial properties. The study was undertaken to assess the antimycobacterial potential of A. galanga in axenic (under aerobic and anaerobic conditions) and intracellular assays.
- 4 March 2014
- Published by Springer Nature in BMC Complementary and Alternative Medicine
- Vol. 14 (1) , 84
Open AccessEvaluating the anti Mycobacterium tuberculosis activity of Alpinia galanga (L.) Willd. axenically under reducing oxygen conditions and in intracellular assays
In tuberculosis (TB), the steadily increasing bacterial resistance to existing drugs and latent TB continue to be major concerns. A combination of conventional drugs and plant derived therapeutics can serve to expand the antimicrobial spectrum, prevent the emergence of drug resistant mutants and minimize toxicity. Alpinia galanga, used in various traditional medicines, possesses broad spectrum antibacterial properties. The study was undertaken to assess the antimycobacterial potential of A. galanga in axenic (under aerobic and anaerobic conditions) and intracellular assays.